scispace - formally typeset
T

Takeo Yoshikawa

Researcher at RIKEN Brain Science Institute

Publications -  294
Citations -  13261

Takeo Yoshikawa is an academic researcher from RIKEN Brain Science Institute. The author has contributed to research in topics: Single-nucleotide polymorphism & Bipolar disorder. The author has an hindex of 57, co-authored 263 publications receiving 12000 citations. Previous affiliations of Takeo Yoshikawa include Tokyo Medical and Dental University & Tokyo Metropolitan Matsuzawa Hospital.

Papers
More filters
Journal ArticleDOI

Screening for 22q11 deletions in a schizophrenia population

TL;DR: The findings establish the existence of physically near-normal individuals with 22q11.2 deletion among learning disabled or mildly retarded persons with schizophrenia, and indicate that 22q 11.2 deletions does not contribute substantially to the development of schizophrenia in general.
Journal ArticleDOI

Altered RNA editing of serotonin 2C receptor in a rat model of depression.

TL;DR: It is revealed that altered RNA editing in the LH rats and by antidepressants was not explained by altered expression of RNA editing enzymes or their substrates (adenosine deaminases that act on RNA, H TR2C, and spliced form of HTR2C).
Journal ArticleDOI

Preliminary genome-wide association study of bipolar disorder in the Japanese population.

TL;DR: A two‐stage genome‐wide association study of bipolar disorder in Japanese cohorts, which is the first GWAS of BD in the Japanese population, and 89 markers remained nominally significant with the same allele being consistently over‐represented in both the first and the follow‐up stages.